144 related articles for article (PubMed ID: 8760600)
1. Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition.
Baldwin RL; Friess H; Yokoyama M; Lopez ME; Kobrin MS; Büchler MW; Korc M
Int J Cancer; 1996 Jul; 67(2):283-8. PubMed ID: 8760600
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
[TBL] [Abstract][Full Text] [Related]
3. Ligand induced upregulation of the type II transforming growth factor (TGF-beta) receptor enhances TGF-beta responsiveness in COLO-357 cells.
Kleeff J; Wildi S; Friess H; Korc M
Pancreas; 1999 May; 18(4):364-70. PubMed ID: 10231841
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
5. Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2.
Venkatasubbarao K; Ammanamanchi S; Brattain MG; Mimari D; Freeman JW
Cancer Res; 2001 Aug; 61(16):6239-47. PubMed ID: 11507078
[TBL] [Abstract][Full Text] [Related]
6. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
[TBL] [Abstract][Full Text] [Related]
7. Increased tumorigenicity in the human pancreatic cell line MIA PaCa-2 is associated with an aberrant regulation of an IGF-1 autocrine loop and lack of expression of the TGF-beta type RII receptor.
Freeman JW; Mattingly CA; Strodel WE
J Cell Physiol; 1995 Oct; 165(1):155-63. PubMed ID: 7559796
[TBL] [Abstract][Full Text] [Related]
8. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M
Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of TGF-betas and their receptors in human acute pancreatitis.
Friess H; Lu Z; Riesle E; Uhl W; Bründler AM; Horvath L; Gold LI; Korc M; Büchler MW
Ann Surg; 1998 Jan; 227(1):95-104. PubMed ID: 9445116
[TBL] [Abstract][Full Text] [Related]
10. Restoration of transforming growth factor-beta signaling enhances radiosensitivity by altering the Bcl-2/Bax ratio in the p53 mutant pancreatic cancer cell line MIA PaCa-2.
Ahmed MM; Alcock RA; Chendil D; Dey S; Das A; Venkatasubbarao K; Mohiuddin M; Sun L; Strodel WE; Freeman JW
J Biol Chem; 2002 Jan; 277(3):2234-46. PubMed ID: 11694525
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.
Alexander JM; Bikkal HA; Zervas NT; Laws ER; Klibanski A
J Clin Endocrinol Metab; 1996 Feb; 81(2):783-90. PubMed ID: 8636304
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression.
Friess H; Yamanaka Y; Büchler M; Berger HG; Kobrin MS; Baldwin RL; Korc M
Cancer Res; 1993 Jun; 53(12):2704-7. PubMed ID: 8389240
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta receptor expression in human cornea.
Joyce NC; Zieske JD
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):1922-8. PubMed ID: 9331255
[TBL] [Abstract][Full Text] [Related]
14. Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5.
Zeeh F; Witte D; Gädeken T; Rauch BH; Grage-Griebenow E; Leinung N; Fromm SJ; Stölting S; Mihara K; Kaufmann R; Settmacher U; Lehnert H; Hollenberg MD; Ungefroren H
Oncotarget; 2016 Jul; 7(27):41095-41109. PubMed ID: 27248167
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing of TGF-betas and their high-affinity receptors T beta RI, T beta RII and T beta RIII (betaglycan) reveal new variants in human prostatic cells.
Konrad L; Scheiber JA; Völck-Badouin E; Keilani MM; Laible L; Brandt H; Schmidt A; Aumüller G; Hofmann R
BMC Genomics; 2007 Sep; 8():318. PubMed ID: 17845732
[TBL] [Abstract][Full Text] [Related]
16. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.
Kleeff J; Ishiwata T; Maruyama H; Friess H; Truong P; Büchler MW; Falb D; Korc M
Oncogene; 1999 Sep; 18(39):5363-72. PubMed ID: 10498890
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of TGFB receptors and mitogenic effects of TGFB in pancreatic carcinomas.
Jonson T; Albrechtsson E; Axelson J; Heidenblad M; Gorunova L; Johansson B; Höglund M
Int J Oncol; 2001 Jul; 19(1):71-81. PubMed ID: 11408925
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
Jakowlew SB; Moody TW; Mariano JM
Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635
[TBL] [Abstract][Full Text] [Related]
19. Genetic integrity of transforming growth factor beta (TGF-beta) receptors in cervical carcinoma cell lines: loss of growth sensitivity but conserved transcriptional response to TGF-beta.
Kang SH; Won K; Chung HW; Jong HS; Song YS; Kim SJ; Bang YJ; Kim NK
Int J Cancer; 1998 Aug; 77(4):620-5. PubMed ID: 9679767
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of ALK1 in pancreatic carcinoma cells.
Ungefroren H; Schniewind B; Groth S; Chen WB; Müerköster SS; Kalthoff H; Fändrich F
Int J Cancer; 2007 Apr; 120(8):1641-51. PubMed ID: 17230504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
